Stryker AGB II Recall
Health care device manufacturers, despite their high technological know how, have been in the spotlight light recently. It has been established beyond reasonable doubt that not all new innovations are beneficial and safe for use. Stryker’s recall of its ABG II hip prosthesis device happens to be one of the most watched issues involving pharmatceutical healthcare device manufacturers in recent times. The Stryker AGB II hip implant product which was created and developed by a company known as Howmedica, has been named in thousands of health care related lawsuits. One study conducted for the ABG II product analysis revealed that Stryker’s highly innovative and insufficiently tested combination of metal materials which are utilized in the ABG II hip prosthesis, can cause severe bone and tissue damage and other related injuries. As a result, after a large number of patients made their complaints known to Stryker through such communications as Adverse Event Reports and the like, in July of 2012 the Stryker and Howmedica finally recalled the product.
If you happen to be one of the victims who has undergone hip replacement during which Stryker’s ABG II product was implanted in you and you have experienced aches and other discomforts in and about the area of surgery, it is important you seek the advice of a professional about the Stryker hip recall or settlement. The unexpected ABG II recall has made an enormous impact not only on the patients who have undergone the surgery, but has also impacted the surgeons and doctors who have been carrying out the procedure. Stryker’s recall has definitely instilled fear in thousands of individuals that the metallurgic combination of the TMZF alloy along with the device’s Vitallium neck, pose significant risk of tissue destruction due to metallosis. Doctors who were uninformed about the hazards of implanting these dangerous alloys in the human body have become increasingly concerned about the welfare of their patients in dealing with the complications of metallosis. The Pharmaseutical industry’s rush to market with insufficiently tested metal on metal hip devices has generally aroused doubts and public distrust of medical device safety and surgical innovations.